A detailed history of Tower Research Capital LLC (Trc) transactions in Chroma Dex Corp. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 3,370 shares of CDXC stock, worth $18,501. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,370
Previous 12,878 73.83%
Holding current value
$18,501
Previous $35,000 65.71%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.51 - $3.8 $23,865 - $36,130
-9,508 Reduced 73.83%
3,370 $12,000
Q2 2024

Aug 13, 2024

BUY
$2.44 - $4.32 $31,178 - $55,200
12,778 Added 12778.0%
12,878 $35,000
Q1 2024

May 15, 2024

BUY
$1.36 - $3.84 $123 - $349
91 Added 1011.11%
100 $0
Q4 2023

Feb 13, 2024

SELL
$1.28 - $1.6 $5,681 - $7,102
-4,439 Reduced 99.8%
9 $0
Q3 2023

Nov 14, 2023

BUY
$1.36 - $1.77 $4,829 - $6,285
3,551 Added 395.88%
4,448 $6,000
Q2 2023

Aug 14, 2023

SELL
$1.31 - $1.79 $5,833 - $7,970
-4,453 Reduced 83.23%
897 $1,000
Q1 2023

May 09, 2023

SELL
$1.48 - $2.19 $19,963 - $29,540
-13,489 Reduced 71.6%
5,350 $9,000
Q4 2022

Feb 10, 2023

BUY
$1.25 - $1.94 $6,910 - $10,724
5,528 Added 41.53%
18,839 $31,000
Q3 2022

Nov 10, 2022

SELL
$1.19 - $2.06 $32,165 - $55,681
-27,030 Reduced 67.0%
13,311 $16,000
Q2 2022

Aug 15, 2022

BUY
$1.59 - $2.7 $55,762 - $94,691
35,071 Added 665.48%
40,341 $67,000
Q1 2022

May 12, 2022

BUY
$2.02 - $3.92 $1,494 - $2,900
740 Added 16.34%
5,270 $13,000
Q4 2021

Feb 14, 2022

SELL
$3.74 - $6.7 $20,947 - $37,526
-5,601 Reduced 55.29%
4,530 $17,000
Q3 2021

Nov 15, 2021

BUY
$6.05 - $10.41 $48,817 - $83,998
8,069 Added 391.32%
10,131 $64,000
Q2 2021

Aug 16, 2021

SELL
$6.66 - $10.92 $213,366 - $349,844
-32,037 Reduced 93.95%
2,062 $20,000
Q1 2021

May 17, 2021

BUY
$4.59 - $18.74 $72,586 - $296,354
15,814 Added 86.49%
34,099 $319,000
Q4 2020

Feb 16, 2021

SELL
$3.93 - $5.5 $110,625 - $154,819
-28,149 Reduced 60.62%
18,285 $88,000
Q3 2020

Nov 16, 2020

BUY
$4.01 - $5.56 $147,339 - $204,291
36,743 Added 379.15%
46,434 $186,000
Q2 2020

Aug 13, 2020

BUY
$3.0 - $5.52 $19,023 - $35,002
6,341 Added 189.28%
9,691 $44,000
Q1 2020

May 15, 2020

BUY
$2.54 - $4.75 $3,870 - $7,239
1,524 Added 83.46%
3,350 $11,000
Q4 2019

Feb 07, 2020

SELL
$2.83 - $4.61 $8,354 - $13,608
-2,952 Reduced 61.78%
1,826 $8,000
Q3 2019

Nov 05, 2019

BUY
$3.83 - $4.72 $18,299 - $22,552
4,778 New
4,778 $19,000
Q1 2019

May 14, 2019

SELL
$3.2 - $4.19 $14,544 - $19,043
-4,545 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$2.8 - $4.22 $12,107 - $18,247
4,324 Added 1956.56%
4,545 $16,000
Q3 2018

Nov 13, 2018

SELL
$3.5 - $4.91 $2,149 - $3,014
-614 Reduced 73.53%
221 $1,000
Q2 2018

Aug 15, 2018

BUY
$3.22 - $4.43 $2,688 - $3,699
835 New
835 $3,000
Q4 2017

Feb 09, 2018

SELL
$3.88 - $6.96 $4,496 - $8,066
-1,159 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$2.91 - $4.71 $3,372 - $5,458
1,159
1,159 $5,000

Others Institutions Holding CDXC

About ChromaDex Corp.


  • Ticker CDXC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,350,896
  • Market Cap $375M
  • Description
  • ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...
More about CDXC
Track This Portfolio

Track Tower Research Capital LLC (Trc) Portfolio

Follow Tower Research Capital LLC (Trc) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.